Table 1.
Clinical characteristics of study subjects.
| Characteristic | Value (n = 7,013) |
|---|---|
| Age, years | 60.6 ± 12.2 |
| Female sex | 3,035 (43.3) |
| Weight, kg | 65.1 ± 11.5 |
| Height, cm | 161 ± 9 |
| Body mass index, kg/m2 | 24.8 ± 3.3 |
| Systolic blood pressure, mmHg | 129 ± 18 |
| Diastolic blood pressure, mmHg | 77.2 ± 11.3 |
| Heart rate, beats per minutes | 69.3 ± 12.2 |
| Cardiovascular risk factors | |
| Hypertension | 3,331 (47.5) |
| Diabetes mellitus | 1,519 (21.7) |
| Dyslipidemia | 3,474 (49.5) |
| Current smoker | 1,312 (18.7) |
| Obesity (body mass index ≥ 25 kg/m2) | 3,150 (45.1) |
| Previous coronary artery disease | 1,953 (27.8) |
| Previous stroke | 36 (0.5) |
| Laboratory findings | |
| White blood cell count, μl | 7,094 ± 3,201 |
| Hemoglobin, g/dl | 13.5 ± 1.8 |
| Fasting glucose, mg/dl | 118 ± 38 |
| Glycated hemoglobin, % | 6.2 ± 1.0 |
| Estimated glomerular filtration rate, ml/min/1.73 m2 | 86.4 ± 25.3 |
| Total cholesterol, mg/dl | 168 ± 42 |
| Low-density lipoprotein, mg/dl | 100 ± 37 |
| High-density lipoprotein, mg/dl | 48.7 ± 13.1 |
| Triglyceride, mg/dl | 135 ± 103 |
| C-reactive protein, mg/dl | 1.3 ± 4.0 |
| Concomitant vasoactive medications | |
| Calcium channel blockers | 965 (13.8) |
| Beta-blockers | 1,771 (25.3) |
| Renin-angiotensin system blockers | 2,241 (32.0) |
| Statins | 3,108 (44.3) |
Numbers are presented as mean ± SD or n (%).